Allogeneic cell therapies are advancing in clinical trials, requiring oncologists and pathologists to understand the ...

Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...

The Global Primary Cell Culture Market is expected to grow significantly by 2030, fuelled by breakthroughs in the field of cell biology, regenerative medicine, and the development of personalized ...

Explore the growing importance of culture banks in global life sciences research, supporting innovation, and scientific ...

Discover how lab-grown bat organoids and cell lines are revolutionizing virus research and pandemic preparedness worldwide.

In this article, the role of the Incucyte® Live-Cell Analysis System is explored in the context ofmulti-spheroid live cell analysis.

The US Pharmacopeia (USP) announced on Oct. 30, 2023 that ATCC and USP have collaborated to create a set of joint products to advance quality control of biological therapies and vaccines. The six ...

Synthego and ATCC Enter Alliance for Cutting-Edge Gene Editing of Mammalian and Mouse Cell Lines PRESS RELEASE PR Newswire Jun. 28, 2023, 08:00 AM ...

Enabling Rapid CRISPR Results from Discovery to Clinic REDWOOD CITY, Calif., June 28, 2023 /PRNewswire/ -- Synthego, a leading genome engineering company, is pleased to announce a groundbreaking ...

ATCC Cell Line Land gives you access to standardized, authenticated and reproducible cell line 'omics data characterizations which can be traced back to physical lots of cells in ATCC's biorepository.

ATCC offers credible, authenticated and characterized cell lines, primary tissue and primary cells to enable reproducible research results. The advantage of working with ‘omics data from ATCC cell ...